Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06841848 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fundus Camera Module for Early Detection of Alzheimer's Disease

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 24, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Study First Submitted
Alzheimer's Disease (AD) affects tens of millions of people just in Europe. It is typically detected in its late stage when irreversible damage has already occurred, and current treatments are mostly conservative or palliative. Here we developed a device performing high-resolution multispectral imaging of the eye fundus to detect AD in its early stage. After clinical testing, the proposed device has a high potential to become a method for routine population screening, as it is non-invasive and affordable. The possibility of AD detection in an early stage is crucial for developing a new pharmaceutical treatment that would dramatically improve the lives of millions and save the expenses connected to lifelong healthcare assistance to people with AD in later stages.
Trial Details
NCT Number NCT06841848
Lead Sponsor I.R.C.C.S. Fondazione Santa Lucia
Conditions
(from sponsor)
Alzheimer Disease
Related terms Alzheimer Disease
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov